Metagenomi, Inc. Common Stock (MGX)
USD 1.39
(10.32%)
USD 1.39
(10.32%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 500.42 Million USD | 2.35% |
| 2022 | 488.91 Million USD | 180.12% |
| 2021 | 174.53 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 116.48 Million USD | -16.66% |
| 2024 Q1 | 139.77 Million USD | -72.07% |
| 2023 Q4 | 500.42 Million USD | -0.99% |
| 2023 Q3 | 505.45 Million USD | -1.12% |
| 2023 FY | 500.42 Million USD | 2.35% |
| 2023 Q2 | 511.19 Million USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2022 FY | 488.91 Million USD | 180.12% |
| 2022 Q4 | 488.91 Million USD | 0.0% |
| 2021 FY | 174.53 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -49.036% |
| Alkermes plc | 933.53 Million USD | 46.395% |
| Agenus Inc. | 462.29 Million USD | -8.248% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 87.645% |
| Aptorum Group Limited | 5.25 Million USD | -9419.706% |
| Ardelyx, Inc. | 130.76 Million USD | -282.697% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -4.606% |
| Bicycle Therapeutics plc | 224.41 Million USD | -122.994% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -284.322% |
| ChromaDex Corporation | 26.5 Million USD | -1787.83% |
| Chimerix, Inc. | 19.74 Million USD | -2434.444% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1322.59% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -589.605% |
| CRISPR Therapeutics AG | 346.76 Million USD | -44.311% |
| Precision BioSciences, Inc. | 140.92 Million USD | -255.114% |
| Dyadic International, Inc. | 2.34 Million USD | -21279.779% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -2977.083% |
| Fortress Biotech, Inc. | 165.93 Million USD | -201.572% |
| Lantern Pharma Inc. | 2.73 Million USD | -18165.843% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -600.092% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -14081.496% |
| Incyte Corporation | 1.59 Billion USD | 68.572% |
| IO Biotech, Inc. | 17.55 Million USD | -2750.456% |
| Jaguar Health, Inc. | 45.86 Million USD | -991.061% |
| Novavax, Inc. | 2.57 Billion USD | 80.545% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1287.836% |
| Opthea Limited | 264.6 Million USD | -89.125% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -282.861% |
| ContextLogic Inc. | 206 Million USD | -142.925% |
| MiMedx Group, Inc. | 96.33 Million USD | -419.491% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -942.077% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -14080.845% |
| NextCure, Inc. | 14.99 Million USD | -3236.841% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -12280.653% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -7394.773% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -970.682% |
| Vaxcyte, Inc. | 167.44 Million USD | -198.853% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1404.627% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -112.753% |
| Pharming Group N.V. | 244.07 Million USD | -105.031% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -4097.5% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -291.597% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -7473.859% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -7473.859% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -507.07% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -7433.133% |
| Acelyrin, Inc. | 86.35 Million USD | -479.512% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -38416.796% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -3380.256% |
| Summit Therapeutics Inc. | 125.25 Million USD | -299.519% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -5179.312% |
| Senti Biosciences, Inc. | 52.57 Million USD | -851.905% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -627.607% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -230.288% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -25484.151% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -37369.264% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -120.615% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -5242.436% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -120.021% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -1.197% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -4485.175% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -1719.003% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -4034.147% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -2.841% |
| Immix Biopharma, Inc. | 3.72 Million USD | -13345.867% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1223.458% |
| MEI Pharma, Inc. | 8.35 Million USD | -5889.539% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1624.715% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -43.974% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -243.065% |
| Fortress Biotech, Inc. | 165.93 Million USD | -201.572% |
| Precigen, Inc. | 41.64 Million USD | -1101.676% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -902.255% |
| AlloVir, Inc. | 45.01 Million USD | -1011.687% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -283.948% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -263.154% |
| ImmuCell Corporation | 18.81 Million USD | -2559.715% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1672.926% |
| Onconetix, Inc. | 23.18 Million USD | -2058.787% |
| PureTech Health plc | 125.58 Million USD | -298.482% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -5491.352% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1359.734% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -20367.321% |
| Seer, Inc. | 39.36 Million USD | -1171.246% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -709.306% |
| Innoviva, Inc. | 568.55 Million USD | 11.982% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -1737.91% |
| ESSA Pharma Inc. | 3.49 Million USD | -14218.05% |
| GlycoMimetics, Inc. | 6.9 Million USD | -7150.371% |
| GT Biopharma, Inc. | 6.63 Million USD | -7444.49% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -89.276% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -83.786% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -495.561% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -5019.971% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -1741.901% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -15413.367% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -578.387% |
| Aptose Biosciences Inc. | 15.8 Million USD | -3065.51% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -4432.973% |
| Soligenix, Inc. | 7.27 Million USD | -6778.799% |
| Century Therapeutics, Inc. | 175.94 Million USD | -184.428% |
| Kura Oncology, Inc. | 51.66 Million USD | -868.654% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -312.614% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -12008.057% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -7466.329% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -98.112% |
| Autolus Therapeutics plc | 263.9 Million USD | -89.622% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -4674.146% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -463.156% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -967.029% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -41.822% |
| GRI Bio, Inc. | 2.69 Million USD | -18454.913% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -61712.657% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1509.553% |
| IGM Biosciences, Inc. | 220.17 Million USD | -127.284% |
| INmune Bio, Inc. | 18.86 Million USD | -2553.091% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -95.114% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1778.348% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -18308.803% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -15155.653% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -756.088% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -420.415% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -89.029% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 39.197% |
| Verastem, Inc. | 71.18 Million USD | -602.994% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -917.622% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1197.18% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -922.697% |
| Histogen Inc. | 5.69 Million USD | -8684.027% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -11310.649% |
| Surrozen, Inc. | 8.14 Million USD | -6043.966% |
| Organovo Holdings, Inc. | 2.74 Million USD | -18110.553% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -159343.443% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -789.964% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -2930.681% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -879.25% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -60420.151% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -294.891% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -4527.751% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -231.652% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -19092.934% |
| Apollomics, Inc. | 14.15 Million USD | -3435.83% |
| Amarin Corporation plc | 279.58 Million USD | -78.988% |
| Mesoblast Limited | 188.79 Million USD | -165.059% |
| Turnstone Biologics Corp. | 14.14 Million USD | -3437.079% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -176.803% |
| Synaptogenix, Inc. | 5.52 Million USD | -8950.164% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -7427.467% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -194.181% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -5748.016% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -28375.475% |
| Exelixis, Inc. | 678.44 Million USD | 26.239% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1998.926% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -205.052% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 15.783% |
| NLS Pharmaceutics AG | 10.68 Million USD | -4585.547% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -30721.697% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -1185.55% |
| Gritstone bio, Inc. | 125.91 Million USD | -297.419% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3309.826% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -9734.205% |
| Avid Bioservices, Inc. | 275.66 Million USD | -81.532% |
| Insmed Incorporated | 1.66 Billion USD | 69.886% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -6404.087% |
| MediWound Ltd. | 27.18 Million USD | -1740.681% |
| OmniAb, Inc. | 87.4 Million USD | -472.57% |
| Alector, Inc. | 487.66 Million USD | -2.616% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -24.035% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -2616.016% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -1204.11% |
| Zai Lab Limited | 240.17 Million USD | -108.357% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 20.575% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1612.204% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -426.338% |
| Immunic, Inc. | 25.36 Million USD | -1872.666% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -622.783% |
| Veracyte, Inc. | 93.71 Million USD | -433.964% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -19024.514% |
| FibroGen, Inc. | 585.72 Million USD | 14.563% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2778.824% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -76525.998% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -8748.549% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 93.464% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -6004.245% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -495.589% |
| TG Therapeutics, Inc. | 169.08 Million USD | -195.961% |
| Galecto, Inc. | 5.89 Million USD | -8387.551% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -5940.874% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 80.888% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1636.264% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -3865.027% |
| XBiotech Inc. | 8.39 Million USD | -5859.581% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3309.826% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -841.004% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -37.818% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -1761.427% |
| Theravance Biopharma, Inc. | 169 Million USD | -196.103% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 58.833% |
| Vaxxinity, Inc. | 30.94 Million USD | -1517.199% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 48.542% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -8197.415% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 32.85% |
| NexImmune, Inc. | 5.08 Million USD | -9742.706% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -134642.618% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -16174.821% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 92.959% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -9609.412% |
| Scopus BioPharma Inc. | 7.45 Million USD | -6613.132% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -1803.195% |
| Ainos, Inc. | 7.39 Million USD | -6667.797% |
| Pluri Inc. | 34.11 Million USD | -1367.009% |
| Prothena Corporation plc | 135.01 Million USD | -270.639% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -105.849% |
| Celularity Inc. | 102.92 Million USD | -386.186% |
| Rallybio Corporation | 9.43 Million USD | -5203.37% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1947.151% |
| MeiraGTx Holdings plc | 319.99 Million USD | -56.388% |
| Omeros Corporation | 403.25 Million USD | -24.098% |
| Humacyte, Inc. | 114.67 Million USD | -336.379% |
| Immunocore Holdings plc | 228.15 Million USD | -119.333% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -10165.149% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -552.106% |
| Blueprint Medicines Corporation | 918.64 Million USD | 45.525% |
| CalciMedica, Inc. | 4.02 Million USD | -12323.684% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -2767.442% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -224.65% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -483.132% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -80.143% |
| Pulmatrix, Inc. | 15.96 Million USD | -3034.912% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -3072.675% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1933.756% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -99.526% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -885.362% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 58.664% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1474.508% |
| Nutriband Inc. | 1.07 Million USD | -46282.166% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -4606.348% |
| Vor Biopharma Inc. | 59.1 Million USD | -746.687% |
| Roivant Sciences Ltd. | 773.95 Million USD | 35.342% |
| Evogene Ltd. | 17.99 Million USD | -2681.69% |
| ProKidney Corp. | 29.21 Million USD | -1612.849% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -595.239% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -70884.123% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 73.507% |
| CorMedix Inc. | 11.91 Million USD | -4099.076% |
| BioLineRx Ltd. | 50.7 Million USD | -886.995% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -234.825% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -465.83% |
| Atai Life Sciences N.V. | 49.16 Million USD | -917.912% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1506.385% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -2686.026% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -301.51% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -8750.831% |
| MediciNova, Inc. | 3.89 Million USD | -12759.288% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -2637.71% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -33167.675% |
| GeoVax Labs, Inc. | 3.51 Million USD | -14117.128% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -25.97% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1530.583% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 81.614% |
| Mereo BioPharma Group plc | 15.96 Million USD | -3035.108% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1503.878% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -752.747% |
| Absci Corporation | 58.3 Million USD | -758.305% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2527.184% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1460.807% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -578.176% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -472.027% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1381.866% |
| Allakos Inc. | 74.79 Million USD | -569.081% |
| Imunon, Inc. | 8.53 Million USD | -5766.365% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -2124.017% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -335.866% |
| BioAtla, Inc. | 48.98 Million USD | -921.569% |
| NLS Pharmaceutics AG | 10.68 Million USD | -4585.547% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -17907.413% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -283.163% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -3420.408% |
| XOMA Corporation | 145.58 Million USD | -243.746% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1386.487% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -627.797% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1483.777% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -709.45% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -1012.923% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -933.895% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -17336.446% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -6034.162% |
| Akari Therapeutics, Plc | 4.58 Million USD | -10816.798% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2721.983% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 69.661% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -123796.036% |
| UroGen Pharma Ltd. | 243.52 Million USD | -105.494% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -55.854% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -18021.148% |
| Orgenesis Inc. | 35.53 Million USD | -1308.262% |
| Entera Bio Ltd. | 1.37 Million USD | -36189.05% |
| GH Research PLC | 6.7 Million USD | -7367.93% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -7259.206% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -2558.164% |
| Xencor, Inc. | 283.55 Million USD | -76.48% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -16660.9% |
| Replimune Group, Inc. | 113.21 Million USD | -342.018% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -13219.386% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -383.363% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -123796.036% |
| Portage Biotech Inc. | 4.45 Million USD | -11145.528% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -33167.675% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -2071.046% |
| OncoCyte Corporation | 49.29 Million USD | -915.104% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -11996.92% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -62650.601% |
| Purple Biotech Ltd. | 10 Million USD | -4901.759% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -8548.911% |
| scPharmaceuticals Inc. | 57.26 Million USD | -773.939% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -3939.596% |
| HilleVax, Inc. | 78.9 Million USD | -534.181% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -9809.426% |
| Tharimmune, Inc. | 1.81 Million USD | -27470.982% |
| Genprex, Inc. | 3.25 Million USD | -15277.812% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -1745.297% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -9457.41% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -242825.243% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -139470.155% |
| OKYO Pharma Limited | 7.42 Million USD | -6643.517% |
| Savara Inc. | 37.19 Million USD | -1245.521% |
| Curis, Inc. | 57.61 Million USD | -768.614% |
| Daré Bioscience, Inc. | 26.32 Million USD | -1800.603% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1176.604% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -34555.54% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -2303.699% |
| BeiGene, Ltd. | 2.23 Billion USD | 77.597% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -2250.543% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -90.713% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -2252.289% |
| Erasca, Inc. | 78.61 Million USD | -536.585% |
| bluebird bio, Inc. | 424.62 Million USD | -17.852% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -76271.533% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 73.523% |
| DBV Technologies S.A. | 42.8 Million USD | -1069.22% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -76271.533% |
| Moderna, Inc. | 4.57 Billion USD | 89.055% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -7054.053% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -30118.961% |
| Molecular Templates, Inc. | 31.17 Million USD | -1505.422% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -2831.611% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 14.908% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -301.932% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -1723.909% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1272.685% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -799.481% |
| MacroGenics, Inc. | 154.2 Million USD | -224.516% |
| RenovoRx, Inc. | 4.46 Million USD | -11105.24% |
| Adicet Bio, Inc. | 37.12 Million USD | -1248.13% |
| Prime Medicine, Inc. | 60.78 Million USD | -723.34% |
| Aditxt, Inc. | 28.53 Million USD | -1653.939% |
| Adagene Inc. | 45.16 Million USD | -1007.889% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -276835.933% |
| Quantum-Si incorporated | 26.63 Million USD | -1779.111% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 28.261% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -16348.191% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -335.301% |
| SciSparc Ltd. | 1.59 Million USD | -31274.671% |
| Vericel Corporation | 127.7 Million USD | -291.861% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -8892.552% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -486.267% |
| Generation Bio Co. | 171.63 Million USD | -191.573% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -4232.693% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1096.304% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -98.033% |
| Invivyd, Inc. | 51.71 Million USD | -867.699% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -444.077% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -7592.647% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -562.851% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -48913.32% |
| 2seventy bio, Inc. | 310.12 Million USD | -61.362% |
| ADMA Biologics, Inc. | 193.97 Million USD | -157.983% |
| Clene Inc. | 38.95 Million USD | -1184.758% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1284.961% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -94.736% |
| GeoVax Labs, Inc. | 3.51 Million USD | -14117.128% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -163.018% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -4008.702% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -152.33% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -4003.602% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -940.149% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -847.041% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -35.304% |
| Evaxion Biotech A/S | 17.61 Million USD | -2740.508% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -210.961% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -226.679% |
| Trevena, Inc. | 48.26 Million USD | -936.894% |
| Surrozen, Inc. | 8.14 Million USD | -6043.966% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -2217.323% |
| Cingulate Inc. | 10.36 Million USD | -4729.964% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -18097.309% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1241.912% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -13852.968% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -3705.521% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -57.763% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1913.868% |
| Clearmind Medicine Inc. | 3.61 Million USD | -13762.185% |
| Kronos Bio, Inc. | 54.2 Million USD | -823.278% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -963.763% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2098.734% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -2393.279% |
| Statera Biopharma, Inc. | 22.67 Million USD | -2106.809% |
| ImmunityBio, Inc. | 1.09 Billion USD | 54.106% |
| Korro Bio, Inc. | 51.75 Million USD | -866.969% |
| Kineta, Inc. | 7.22 Million USD | -6829.189% |
| BioVie Inc. | 9.7 Million USD | -5057.898% |
| Codexis, Inc. | 49.94 Million USD | -901.934% |
| Celularity Inc. | 102.92 Million USD | -386.186% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -419.939% |
| Celcuity Inc. | 51.45 Million USD | -872.644% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -144869.495% |
| Cibus, Inc. | 206.11 Million USD | -142.787% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1078.166% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -1799.943% |
| IN8bio, Inc. | 8.77 Million USD | -5604.811% |
| Kodiak Sciences Inc. | 213.59 Million USD | -134.292% |
| Annexon, Inc. | 47.11 Million USD | -962.07% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -458.879% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -419.265% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -3555.68% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 80.778% |
| Eyenovia, Inc. | 19.78 Million USD | -2429.924% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -182.589% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -6415.115% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1976.543% |
| Arcellx, Inc. | 339.75 Million USD | -47.292% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -4105.967% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -103.806% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -5132.939% |
| Moolec Science SA | 13.94 Million USD | -3488.478% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1059.682% |
| Geron Corporation | 146.12 Million USD | -242.46% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -890.315% |
| Royalty Pharma plc | 6.29 Billion USD | 92.054% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1158.11% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -169878.193% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -20240.189% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -164.557% |
| Humacyte, Inc. | 114.67 Million USD | -336.379% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1622.577% |
| 89bio, Inc. | 59.96 Million USD | -734.558% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -1791.04% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -41741.639% |
| Genelux Corporation | 8.42 Million USD | -5843.302% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -7199.096% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -267.099% |
| Notable Labs, Ltd. | 4.42 Million USD | -11203.953% |
| Liquidia Corporation | 73.13 Million USD | -584.222% |
| Mustang Bio, Inc. | 17.61 Million USD | -2740.263% |
| Immunovant, Inc. | 48.95 Million USD | -922.216% |
| Quantum-Si incorporated | 26.63 Million USD | -1779.111% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1203.77% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -16027.167% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -577.524% |
| Acasti Pharma Inc. | 11.55 Million USD | -4230.068% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -2113.517% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -18308.803% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1257.014% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -36619.297% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -8109.088% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1915.003% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -2058.497% |
| PepGen Inc. | 34.63 Million USD | -1345.023% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -4020.767% |
| United Therapeutics Corporation | 1.18 Billion USD | 57.67% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -7065.321% |
| Solid Biosciences Inc. | 38.45 Million USD | -1201.227% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -5748.016% |
| Immuneering Corporation | 12 Million USD | -4067.315% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -159343.443% |
| Silo Pharma, Inc. | 1.56 Million USD | -31789.095% |
| Belite Bio, Inc | 4.21 Million USD | -11783.781% |
| XOMA Corporation | 145.58 Million USD | -243.746% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -20510.626% |
| Bionomics Limited | 10.15 Million USD | -4826.073% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -2228.538% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2084.027% |
| uniQure N.V. | 624.01 Million USD | 19.806% |
| Cassava Sciences, Inc. | 14.19 Million USD | -3425.368% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -276835.933% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -194.05% |
| Forte Biosciences, Inc. | 3.66 Million USD | -13550.464% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -191940.924% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -7317.015% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -6415.115% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2778.824% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -4635.295% |
| Altimmune, Inc. | 16.54 Million USD | -2925.367% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 18.986% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2084.027% |
| Compugen Ltd. | 55.77 Million USD | -797.223% |
| Peak Bio, Inc. | 20.75 Million USD | -2311.301% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -353.026% |
| Benitec Biopharma Inc. | 4.96 Million USD | -9985.167% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -217.04% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -565.69% |
| Zura Bio Limited | 21.29 Million USD | -2250.301% |
| PolyPid Ltd. | 17.46 Million USD | -2764.816% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -345.223% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -565.69% |
| Instil Bio, Inc. | 99.8 Million USD | -401.424% |
| argenx SE | 444.95 Million USD | -12.468% |
| Immunome, Inc. | 28.65 Million USD | -1646.2% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -5902.471% |
| Verona Pharma plc | 58.84 Million USD | -750.472% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -3357.652% |
| Shattuck Labs, Inc. | 14.85 Million USD | -3267.831% |
| CervoMed Inc. | 2.59 Million USD | -19178.689% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -10167.255% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -3829.224% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -4650.128% |
| Moolec Science SA | 13.94 Million USD | -3488.478% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -21253.751% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -800.123% |
| AnaptysBio, Inc. | 364.28 Million USD | -37.372% |
| Design Therapeutics, Inc. | 11.95 Million USD | -4085.564% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -3845.333% |
| NeurAxis, Inc. | 1.91 Million USD | -26062.796% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1185.517% |
| Lumos Pharma, Inc. | 13.33 Million USD | -3653.289% |
| Achilles Therapeutics plc | 19.08 Million USD | -2521.816% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -3357.652% |
| 180 Life Sciences Corp. | 5.38 Million USD | -9189.151% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -2021.529% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2098.734% |
| Nutriband Inc. | 1.07 Million USD | -46282.166% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1535.486% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -3348.598% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -24.709% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1441.053% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -3734.948% |
| Palisade Bio, Inc. | 2.73 Million USD | -18170.391% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -9426.48% |
| Beam Therapeutics Inc. | 478.38 Million USD | -4.607% |
| Neurogene Inc. | 36.54 Million USD | -1269.192% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -25.751% |
| AEON Biopharma, Inc. | 159.88 Million USD | -212.983% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -950.212% |
| Sesen Bio, Inc. | 30.98 Million USD | -1515.111% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -1827.607% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -6482.633% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -155.661% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -160.561% |
| Athira Pharma, Inc. | 30.05 Million USD | -1564.923% |
| Vaccinex, Inc. | 5.94 Million USD | -8321.844% |
| HCW Biologics Inc. | 15.05 Million USD | -3224.66% |
| XOMA Corporation | 145.58 Million USD | -243.746% |
| Nektar Therapeutics | 267.04 Million USD | -87.393% |
| Arvinas, Inc. | 644.6 Million USD | 22.366% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2721.983% |
| Merus N.V. | 102.15 Million USD | -389.888% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -241.938% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -426.1% |
| Rezolute, Inc. | 11.73 Million USD | -4164.752% |
| Clene Inc. | 38.95 Million USD | -1184.758% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -17474.964% |
| BeyondSpring Inc. | 48.26 Million USD | -936.744% |
| Synlogic, Inc. | 32.89 Million USD | -1421.283% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -3324.526% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -30525.826% |
| Peak Bio, Inc. | 20.75 Million USD | -2311.301% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -688.582% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1160.075% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -32.864% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -402.592% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -115545.004% |
| MannKind Corporation | 721.36 Million USD | 30.628% |
| Ikena Oncology, Inc. | 22.33 Million USD | -2140.546% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -23889.741% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -387.792% |
| Gossamer Bio, Inc. | 249.14 Million USD | -100.856% |
| CohBar, Inc. | 1.03 Million USD | -48314.048% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -4581.691% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2527.184% |
| Legend Biotech Corporation | 589.93 Million USD | 15.172% |
| Mural Oncology plc | 37.92 Million USD | -1219.41% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -277.293% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -21701.901% |
| Disc Medicine, Inc. | 22.87 Million USD | -2087.655% |
| Champions Oncology, Inc. | 28.03 Million USD | -1685.004% |
| REGENXBIO Inc. | 262.22 Million USD | -90.836% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -14796.504% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -3892.548% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -3625.729% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -2259.943% |
| Vaxart, Inc. | 34.02 Million USD | -1370.76% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -2354.36% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1653.919% |
| Cellectis S.A. | 249.57 Million USD | -100.511% |
| Longeveron Inc. | 5.33 Million USD | -9276.541% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1096.647% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 79.194% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -728.959% |
| Revolution Medicines, Inc. | 262.39 Million USD | -90.713% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -23650.641% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -5701.368% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -4140.539% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -3463.526% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -23164.807% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 90.283% |
| Denali Therapeutics Inc. | 122.96 Million USD | -306.973% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -8892.552% |
| Veru Inc. | 32.81 Million USD | -1425.098% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -7185.282% |
| Cingulate Inc. | 10.36 Million USD | -4729.964% |
| Passage Bio, Inc. | 39.26 Million USD | -1174.581% |
| Context Therapeutics Inc. | 4.19 Million USD | -11838.455% |
| Exicure, Inc. | 8.54 Million USD | -5753.62% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1595.899% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -4672.325% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -2170.432% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -207.036% |
| Nuvalent, Inc. | 31.82 Million USD | -1472.529% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -7766.321% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -694.05% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -2680.144% |
| OmniAb, Inc. | 87.4 Million USD | -472.57% |
| Anew Medical, Inc. | 8.24 Million USD | -5971.805% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1206.967% |
| Lipocine Inc. | 2.63 Million USD | -18915.826% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -1804.788% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1144.469% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1778.348% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -480.851% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -9165.432% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -504.766% |
| Ocugen, Inc. | 23.98 Million USD | -1986.586% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -978.342% |
| Q32 Bio Inc. | 233.12 Million USD | -114.657% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -5419.81% |
| Alumis Inc. Common Stock | 53.5 Million USD | -835.341% |
| Equillium, Inc. | 27.95 Million USD | -1689.985% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -142.229% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -8793.83% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -8059.606% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -218.082% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -620.732% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -4917.204% |
| Dominari Holdings Inc. | 4.63 Million USD | -10696.677% |
| Edesa Biotech, Inc. | 1.84 Million USD | -27072.89% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1592.515% |
| Bio-Techne Corporation | 744.34 Million USD | 32.769% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -296.852% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -45.28% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1133.336% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1628.169% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -441.821% |
| Nkarta, Inc. | 105.6 Million USD | -373.888% |
| BioCardia, Inc. | 4.59 Million USD | -10802.527% |
| Iterum Therapeutics plc | 32.66 Million USD | -1432.135% |